Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Hematology  |  Nephrology  |  Oncology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Blood Cancer Clinical Trials

A listing of Blood Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1296) clinical trials

Primary Outcome Measures:1. Antitumor activity [ Time Frame: Through Month 24 ]Overall response rate (complete response + partial response) based on "Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification"Secondary Outcome Measures:1. Adverse events [ Time Frame: 90 days ]Proportion of subjects experiencing ...

Phase

People with multiple myeloma are asked to participate in a research study being conducted by Montefiore Medical Center.  

Phase N/A

A research study is evaluating the performance of a DNA test for colorectal cancer and advanced adenoma in patients scheduled to undergo a colonoscopy.  

Phase N/A

Blood Sample Collection in Subjects with Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer  

Phase N/A

People with multiple myeloma are asked to participate in a research study being conducted by Northwell Health  

Phase N/A

The purpose of this study is to evaluate the safety and antitumor activity of INCB001158 in combination with daratumumab SC, compared with daratumumab SC alone, in participants with relapsed or refractory multiple myeloma who have received at least 3 but not more than 5 prior lines of multiple myeloma therapy. ...

Phase

People with hematological cancers are asked to participate in a research study being conducted by CLL Research and Treatment Program/Northwell Health Cancer Institute//Feinstein Institute for Medical Research and Zucker School of Medicine at Hofstra-Northwell  

Phase N/A

A research study is evaluating biomarkers in blood samples from adults with untreated melanoma to assist in future diagnostic tests.  

Phase N/A

A research study is evaluating biomarkers in blood samples from adults with untreated hematologic malignancies blood or lymphatic cancers to assist in future diagnostic tests.  

Phase

The purpose of this study is to evaluate the efficacy and safety of itacitinib combined with low-dose ruxolitinib or itacitinib alone in subjects with myelofibrosis.   This is an open-label Phase 2 study with 2 cohorts: Cohort A: Itacitinib plus ruxolitinib  Drug: Itacitinib self-administered orally once daily at the   protocol-defined ...

Phase